Drug News
-
Regeneron’s Breakthrough Treatment, Veopoz, Granted FDA Approval for Rare Disease
In a significant development, Regeneron Pharmaceuticals, Inc. has announced the approval of Veopoz™ (pozelimab-bbfg) by the U.S. Food and Drug…
Read More » -
MSF Challenges GSK’s Contract Clauses for Access to Apretude
Médecins Sans Frontières (MSF), an international medical humanitarian organization, has been diligently working to secure access to ViiV Healthcare’s innovative…
Read More » -
Tukysa’s Trial Success Spurs Roche’s Kadcyla and Pfizer’s $43B Acquisition
Pfizer’s strategic move to acquire Seagen for $43 billion is primarily motivated by the Seattle biotech’s advantage in the field…
Read More » -
FDA Issues Warning to AstraZeneca for Misleading COPD Drug Advertising
The absence of any drug that demonstrates a significant improvement in all-cause mortality among patients with chronic obstructive pulmonary disease…
Read More » -
Tornado Fallout: 50% of Pfizer Hospital Injectables in Short Supply
As of August 16, 2023, approximately half of the injectable drug solutions produced by Pfizer Hospital US are experiencing significant…
Read More » -
Breaking Ground: FDA Approves Akeega for Aggressive Prostate Cancer Treatment
The U.S. Food & Drug Administration’s approval of Akeega marks a significant advancement in the treatment landscape for individuals with…
Read More » -
Why Eligible Infants and Children Should Get The New RSV Medication – AAP
Respiratory Syncytial Virus (RSV) is a widespread viral infection that predominantly targets the respiratory system, particularly the lungs and airways.…
Read More » -
Ipsen’s Sohonos (palovarotene) Capsules Approved by FDA for Managing Debilitating Bone Disorder
In a landmark development, Ipsen has officially received approval from the U.S. Food and Drug Administration (FDA) for its groundbreaking…
Read More » -
Ozempic’s Financial Triumphs and the CMS Negotiation Horizon
Ozempic, a prominent Type 2 diabetes drug, appears to be at the cusp of potential involvement with the Centers for…
Read More » -
UK NHS Joins Forces with IAOCR to Launch Clinical Trials Talent Taskforce
In a pivotal stride towards revitalizing the landscape of clinical research, the United Kingdom’s National Health Service (NHS) has forged…
Read More »